NEW YORK (GenomeWeb News) – The ALS Therapy Development Institute, a non-profit that is focused on advancing research into amyotrophic lateral sclerosis, or Lou Gehrig’s disease, said today that it is accelerating its efforts to discover biomarkers that could be used in combating the disease.

The group said it is expanding its effort to collect samples for use in the program, which seeks to identify altered expression of genes and proteins that could be potential biomarkers for diagnosing and monitoring the disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.